Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001231589-26-000002

EVP & GENERAL COUNSEL sold 8,300 shares at an average $469.89 ($3,900,122)

  • EVP & GENERAL COUNSEL acquired 8,300 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MAHON PAUL A · EVP & GENERAL COUNSEL

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-15 Exercise or conversion : show line 1 in the form 10b5-1 +8,300 $146.03 $1,212,049 45,081 D
2026-01-15 Sale : show line 2 in the form 10b5-1 −1,439 $468.32 $673,918 43,642 D
2026-01-15 Sale : show line 3 in the form 10b5-1 −1,307 $470.37 $614,769 42,335 D
2026-01-15 Sale : show line 4 in the form 10b5-1 −407 $472.28 $192,219 41,928 D
2026-01-15 Sale : show line 5 in the form 10b5-1 −3,531 $469.34 $1,657,237 38,397 D
2026-01-15 Sale : show line 6 in the form 10b5-1 −1,576 $471.44 $742,990 36,821 D
2026-01-15 Sale : show line 7 in the form 10b5-1 −40 $474.74 $18,990 36,781 D
Open-market sales · 8,300 sh · avg $469.89 · $3,900,122

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-15 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option −8,300 58,400 D
Loading xslF345X05/primarydocument.xml…